Telisotuzumab vedotin (teliso-v) monotherapy in patients with previously treated c-Met+ advanced non-small cell lung cancer.
dc.authorid | Bar, Jair/0000-0002-1224-3646 | |
dc.authorid | Moiseenko, Fedor/0000-0003-2544-9042 | |
dc.authorwosid | Bar, Jair/AAS-5743-2021 | |
dc.authorwosid | Filippova, Elena/AAE-2696-2022 | |
dc.authorwosid | Moiseenko, Fedor/E-1775-2014 | |
dc.contributor.author | Camidge, D. Ross | |
dc.contributor.author | Moiseenko, Fedor | |
dc.contributor.author | Cicin, Irfan | |
dc.contributor.author | Horinouchi, Hidehito | |
dc.contributor.author | Filippova, Elena | |
dc.contributor.author | Bar, Jair | |
dc.contributor.author | Lu, Shun | |
dc.date.accessioned | 2024-06-12T11:23:59Z | |
dc.date.available | 2024-06-12T11:23:59Z | |
dc.date.issued | 2021 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description | Annual Meeting of the American-Association-for-Cancer-Research (AACR) -- APR 10-MAY 21, 2021 -- Philadelphia, PA | en_US |
dc.description.abstract | [Abstract Not Available] | en_US |
dc.description.sponsorship | Amer Assoc Canc Res | en_US |
dc.identifier.issn | 0008-5472 | |
dc.identifier.issn | 1538-7445 | |
dc.identifier.issue | 13 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/26756 | |
dc.identifier.volume | 81 | en_US |
dc.identifier.wos | WOS:000680263501335 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Amer Assoc Cancer Research | en_US |
dc.relation.ispartof | Cancer Research | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | [No Keywords] | en_US |
dc.title | Telisotuzumab vedotin (teliso-v) monotherapy in patients with previously treated c-Met+ advanced non-small cell lung cancer. | en_US |
dc.type | Conference Object | en_US |